OS Therapies Financials
| OSTX Stock | 3.97 0.06 1.53% |
Short Ratio 0.01 | EPS Estimate Current Year (1.13) |
The essential information of the day-to-day investment outlook for OS Therapies includes many different criteria found on its balance sheet. An individual investor should monitor OS Therapies' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in OS Therapies.
Net Income |
|
OSTX |
Please note, the imprecision that can be found in OS Therapies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OS Therapies Incorporated. Check OS Therapies' Beneish M Score to see the likelihood of OS Therapies' management manipulating its earnings.
OS Therapies Stock Summary
OS Therapies competes with Montauk Renewables, Digi International, Anterix, Radcom, and Sphere Entertainment. OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NYSE MKT Exchange |
| CUSIP | 68764Y207 |
| Location | Maryland; U.S.A |
| Business Address | 15825 Shady Grove |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | ostherapies.com |
| Phone | 410 297 7793 |
OS Therapies Key Financial Ratios
| Net Income | (7.79 M) | ||||
| Total Asset | 798.08 K | ||||
| Retained Earnings | (29.52 M) |
OSTX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OS Therapies's current stock value. Our valuation model uses many indicators to compare OS Therapies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OS Therapies competition to find correlations between indicators driving OS Therapies's intrinsic value. More Info.OS Therapies Incorporated is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 0.23 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for OS Therapies Incorporated is roughly 4.34 . Common Stock Shares Outstanding is likely to drop to about 16.5 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OS Therapies' earnings, one of the primary drivers of an investment's value.OS Therapies Systematic Risk
OS Therapies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OS Therapies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on OS Therapies correlated with the market. If Beta is less than 0 OS Therapies generally moves in the opposite direction as compared to the market. If OS Therapies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OS Therapies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OS Therapies is generally in the same direction as the market. If Beta > 1 OS Therapies moves generally in the same direction as, but more than the movement of the benchmark.
OS Therapies December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OS Therapies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OS Therapies Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of OS Therapies Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing OSTX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OS Therapies's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.42 | |||
| Information Ratio | 0.061 | |||
| Maximum Drawdown | 79.09 | |||
| Value At Risk | (12.70) | |||
| Potential Upside | 20.19 |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.